In 2017, I sat down to read a book entitled, A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution. Written by Jennifer Doudna it described a new tool called CRISPR that could edit DNA. Doudna first published a description of this gene editing tool in the journal Science in 2012. I wrote about CRISPR in 2017 and then again following the progress being made using it and the evolution of its tool capabilities as researchers in laboratories around the world discovered novel ways to use it.
In 2019, CRISPR started moving out of university research laboratories and into the world of medical clinical trials. In one case it was used to edit the DNA of T-cells by removing a gene and replacing it with one to attack sarcomas and multiple myelomas. A similar editing experiment replaced a gene in people suffering from beta-thalassemia, a genetic blood disorder. And in another trial, CRISPR-modified bone marrow stem cells were used to eliminate sickle cell anemia.
Among the Massachusetts Institute of Technology’s 10 technology breakthroughs in 2023, CRISPR made the list. Why? Because MIT sees CRISPR’s days in clinical trials around rare diseases coming to an end. The CRISPR of today, eleven years after it first came on the scene, is no longer just a slice-and-dice tool.
CRISPR Going Mainstream
CRISPR is being used by a company, Verve Therapeutics, today, to alter genetic code associated with high cholesterol that is treated using drugs called statins.
I take statins once a day because my cholesterol levels are slightly higher than normal. I remember when it was first prescribed, the doctor said the city should be putting statins in the drinking water just like fluoride because high cholesterol was a huge problem here in North America.
Cholesterol comes in two forms, one good, the other bad. Our bodies need good cholesterol because it is essential to cells. But too much of the bad kind can clog arteries and lead to strokes and heart attacks.
According to the U.S. Centers for Disease Control (CDC), more than half of American adults are on prescribed statins to reduce cholesterol levels. That number isn’t too far different in Canada. But there are problems with being on statins forever. Blood levels have to be checked periodically to ensure the doses are right and cholesterol levels are within the normal range. Statins also have side effects. For instance, when I first started on a statin I had horrific backaches. A pharmacist recommended I take a supplement, CoQ10, with the statin and the problem has never reoccurred.
Genetic Vaccines in Our Future
What Verve is offering instead of a statin, is the first genetic vaccine on the market, a one-time fix to permanently lower bad cholesterol levels. To understand how a genetic vaccine works here is a quick refresher on DNA. It is a complex molecule containing four nucleotides, also called nucleobases. They go by the names adenine, guanine, cytosine and thymine. These are the biological building blocks for life on Earth.
What Verve has done is use CRISPR to edit a single nucleobase within our DNA for PCSK9, a gene expressed in the liver. PCSK9 encodes a protein that regulates the amount of cholesterol in blood plasma. Delivered as a vaccine Verve has shown the treatment lowers blood cholesterol levels by as much as 70% and keeps it down permanently. Limited human testing has shown excellent results. Larger clinical trials are coming up.
From Verve’s curing high cholesterol to the use of CRISPR for genetic vaccines to cure other diseases is not too far in the future. A CRISPR-derived genetic vaccine could lead to a cure for diabetes, high blood pressure, and even Alzheimer’s.
CRISPR for the masses can be revolutionary. It has enormous ramifications for humanity with genetic vaccinations replacing many prescription drugs. And a genetic vaccination will only need to be administered once providing a permanent fix.
Those who see this as us playing God will likely react negatively to this medical breakthrough. I suspect the anti-vaxxers will be out with pitchforks in hand ready to march. And on the Internet conspiracy theorists will spread fear and misinformation about CRISPR and the evil intent of a medical cabal out to take over the world and turn us into zombies. For those who fit into these categories, the option of the prescription pills we have today will still remain.
![](https://www.nanoappsmedical.com/wp-content/uploads/2017/05/spacer.jpg)
News
The Silent Battle Within: How Your Organs Choose Between Mom and Dad’s Genes
Research reveals that selective expression of maternal or paternal X chromosomes varies by organ, driven by cellular competition. A new study published today (July 26) in Nature Genetics by the Lymphoid Development Group at the MRC [...]
Study identifies genes increasing risk of severe COVID-19
Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in [...]
Small regions of the brain can take micro-naps while the rest of the brain is awake and vice versa
Sleep and wake: They're totally distinct states of being that define the boundaries of our daily lives. For years, scientists have measured the difference between these instinctual brain processes by observing brain waves, with [...]
Redefining Consciousness: Small Regions of the Brain Can Take Micro-Naps While the Rest of the Brain Is Awake
The study broadly reveals how fast brain waves, previously overlooked, establish fundamental patterns of sleep and wakefulness. Scientists have developed a new method to analyze sleep and wake states by detecting ultra-fast neuronal activity [...]
AI Reveals Health Secrets Through Facial Temperature Mapping
Researchers have found that different facial temperatures correlate with chronic illnesses like diabetes and high blood pressure, and these can be detected using AI with thermal cameras. They highlight the potential of this technology [...]
Breakthrough in aging research: Blocking IL-11 extends lifespan and improves health in mice
In a recent study published in the journal Nature, a team of researchers used murine models and various pharmacological and genetic approaches to examine whether pro-inflammatory signaling involving interleukin (IL)-11, which activates signaling molecules such [...]
Promise for a universal influenza vaccine: Scientists validate theory using 1918 flu virus
New research led by Oregon Health & Science University reveals a promising approach to developing a universal influenza vaccine—a so-called "one and done" vaccine that confers lifetime immunity against an evolving virus. The study, [...]
New Projects Aim To Pioneer the Future of Neuroscience
One study will investigate the alterations in brain activity at the cellular level caused by psilocybin, the psychoactive substance found in “magic mushrooms.” How do neurons respond to the effects of magic mushrooms? What [...]
Decoding the Decline: Scientific Insights Into Long COVID’s Retreat
Research indicates a significant reduction in long COVID risk, largely due to vaccination and the virus’s evolution. The study analyzes data from over 441,000 veterans, showing lower rates of long COVID among vaccinated individuals compared [...]
Silicon Transformed: A Breakthrough in Laser Nanofabrication
A new method enables precise nanofabrication inside silicon using spatial light modulation and laser pulses, creating advanced nanostructures for potential use in electronics and photonics. Silicon, the cornerstone of modern electronics, photovoltaics, and photonics, [...]
Caught in the actinium: New research could help design better cancer treatments
The element actinium was first discovered at the turn of the 20th century, but even now, nearly 125 years later, researchers still don't have a good grasp on the metal's chemistry. That's because actinium [...]
Innovative Light-Controlled Drugs Could Revolutionize Neuropathic Pain Treatment
A team of researchers from the Institute for Bioengineering of Catalonia (IBEC) has developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. Light can be harnessed to target drugs to specific [...]
Green Gold: Turning E-Waste Into a Treasure Trove of Rare Earth Metals
Scientists are developing a process inspired by nature that efficiently recovers europium from old fluorescent lamps. The approach could lead to the long-awaited recycling of rare earth metals. A small molecule that naturally serves [...]
Cambridge Study: AI Chatbots Have an “Empathy Gap,” and It Could Be Dangerous
A new study suggests a framework for “Child Safe AI” in response to recent incidents showing that many children perceive chatbots as quasi-human and reliable. A study has indicated that AI chatbots often exhibit [...]
Nanoparticle-based delivery system could offer treatment for diabetics with rare insulin allergy
Up to 3% of people with diabetes have an allergic reaction to insulin. A team at Forschungszentrum Jülich has now studied a method that could be used to deliver the active substance into the [...]
Nanorobot kills cancer cells in mice with hidden weapon
Researchers at Karolinska Institutet in Sweden have developed nanorobots that kill cancer cells in mice. The robot's weapon is hidden in a nanostructure and is exposed only in the tumor microenvironment, sparing healthy cells. [...]